Unknown

Dataset Information

0

Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification.


ABSTRACT: BACKGROUND:Phosphate (Pi) toxicity is a strong determinant of vascular calcification development in chronic kidney disease (CKD). Magnesium (Mg2+) may improve cardiovascular risk via vascular calcification. The mechanism by which Mg2+ counteracts vascular calcification remains incompletely described. Here we investigated the effects of Mg2+ on Pi and secondary crystalline calciprotein particles (CPP2)-induced calcification and crystal maturation. METHODS:Vascular smooth muscle cells (VSMCs) were treated with high Pi or CPP2 and supplemented with Mg2+ to study cellular calcification. The effect of Mg2+ on CPP maturation, morphology and composition was studied by medium absorbance, electron microscopy and energy dispersive spectroscopy. To translate our findings to CKD patients, the effects of Mg2+ on calcification propensity (T50) were measured in sera from CKD patients and healthy controls. RESULTS:Mg2+ supplementation prevented Pi-induced calcification in VSMCs. Mg2+ dose-dependently delayed the maturation of primary CPP1 to CPP2 in vitro. Mg2+ did not prevent calcification and associated gene and protein expression when added to already formed CPP2. Confirmatory experiments in human serum demonstrated that the addition of 0.2?mmol/L Mg2+ increased T50 from healthy controls by 51?±?15?min (P?

SUBMITTER: Ter Braake AD 

PROVIDER: S-EPMC7203562 | BioStudies | 2020-01-01

SECONDARY ACCESSION(S): NCT02542319

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5678662 | BioStudies
2019-01-01 | S-EPMC6974455 | BioStudies
1000-01-01 | S-EPMC3904573 | BioStudies
2017-01-01 | S-EPMC5738386 | BioStudies
2015-01-01 | S-EPMC4301909 | BioStudies
2019-11-04 | GSE136593 | GEO
2018-01-01 | S-EPMC6054342 | BioStudies
2018-01-01 | S-EPMC6200237 | BioStudies
2019-01-01 | S-EPMC6832040 | BioStudies
1000-01-01 | S-EPMC6025998 | BioStudies